Literature DB >> 15793332

Confusing brand names: nightmare of medical profession.

P V Rataboli1, A Garg.   

Abstract

OBJECTIVE: India has more than 20,000 registered pharmaceutical manufacturers. Consequently, there is a flood of brand names to choose from. We conducted this study to analyse and sort out the multitudinous brand names thronging the Indian market, and identified those that could create a possible confusion.
MATERIALS AND METHODS: Recent issues of drug formularies like Indian Drug Review, Drug Index, and Monthly Index of Medical Specialities-India were checked and all the brand names given were included. Some other brand names that are available with the pharmacists but are not included in these indexes were also included in the study for analysis. OBSERVATIONS: Potentially confusing brand names were sorted out and categorised according to the severity of damage they can cause if misinterpreted by the pharmacist or the patient. Subgroups were made according to the brand name, the generic name, and the manufacturers of the drug.
CONCLUSION: Several brand names are strikingly identical, similar looking (orthographic), or similar sounding (phonological). Preventing this possible confusion is not the work of any one person involved. We describe the role of prescribing doctors, dispensing pharmacists, consumer patients, and the manufacturing companies to prevent "wrong prescribing" due to similarities in brand names.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793332

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  2 in total

1.  Evaluation of Multimedia Medication Reconciliation Software: A Randomized Controlled, Single-Blind Trial to Measure Diagnostic Accuracy for Discrepancy Detection.

Authors:  Blake J Lesselroth; Kathleen Adams; Victoria L Church; Stephanie Tallett; Yelizaveta Russ; Jack Wiedrick; Christopher Forsberg; David A Dorr
Journal:  Appl Clin Inform       Date:  2018-05-02       Impact factor: 2.342

2.  Prevention strategies to identify LASA errors: building and sustaining a culture of patient safety.

Authors:  Irene Lizano-Díez; Carlos Figueiredo-Escribá; M Ángeles Piñero-López; Cecilia F Lastra; Eduardo L Mariño; Pilar Modamio
Journal:  BMC Health Serv Res       Date:  2020-01-29       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.